Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Circulation|May 22, 2015
Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) StudyYing Xian, Tracy Y Wang, Lisa A McCoy, et al.American Heart Journal|September 21, 2015
Contemporary use of platelet function and pharmacogenomic testing among patients with acute myocardial infarction undergoing percutaneous coronary intervention in the United StatesTracy Y Wang, Timothy D Henry, Lisa A McCoy, et al.American Heart Journal|December 17, 2016
Switching of adenosine diphosphate receptor inhibitor after hospital discharge among myocardial infarction patients: Insights from the Treatment with Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) observational studyMarjorie E Zettler, Eric D Peterson, Lisa A McCoy, et al.Circulation. Cardiovascular Interventions|October 30, 2016
Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome)Emil L Fosbøl, Christine Ju, Kevin J Anstrom, et al.Journal of the American Heart Association|October 30, 2016
Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyLarry R Jackson, Eric D Peterson, Lisa A McCoy, et al.Journal of the American Heart Association|January 27, 2016
How Reliable are Patient-Reported Rehospitalizations? Implications for the Design of Future Practical Clinical StudiesArun Krishnamoorthy, Eric D Peterson, J David Knight, et al.Journal of the American Heart Association|September 25, 2016
Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE-ACS) StudyAmit N Vora, Eric D Peterson, Lisa A McCoy, et al.Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.Journal of the American College of Cardiology|April 23, 2013
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX studyPaul A Gurbel, Kevin P Bliden, Douglas K Logan, et al.American Heart Journal|June 5, 2017
Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS studyUsman Baber, Samantha Sartori, Melissa Aquino, et al.Pageof 3